China Universal Asset Management Company’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$155K Sell
14,128
-1,314
-9% -$12.4K 0.01% 375
2026
Q1
$126K Buy
15,442
+1,263
+9% +$10.8K 0.01% 389
2025
Q4
$147K Sell
14,179
-1,035
-7% -$10.9K 0.01% 378
2025
Q3
$135K Sell
15,214
-2,174
-13% -$15.5K 0.01% 361
2025
Q2
$100K Buy
17,388
+1,190
+7% +$7.29K 0.01% 367
2025
Q1
$107K Sell
16,198
-291
-2% -$2.27K 0.01% 354
2024
Q4
$144K Buy
16,489
+1,750
+12% +$25.2K 0.01% 358
2024
Q3
$288K Buy
14,739
+5,788
+65% +$117K 0.03% 271
2024
Q2
$184K Sell
8,951
-6,666
-43% -$137K 0.03% 251
2024
Q1
$333K Buy
15,617
+7,027
+82% +$137K 0.04% 226
2023
Q4
$124K Buy
8,590
+6,692
+353% +$65.8K 0.02% 255
2023
Q3
$17.3K Buy
1,898
+1,001
+112% +$10.2K 0.01% 308
2023
Q2
$9.49K Sell
897
-31
-3% -$367 ﹤0.01% 324
2023
Q1
$11.3K Buy
928
+235
+34% +$2.93K ﹤0.01% 278
2022
Q4
$8.6K Buy
693
+67
+11% +$974 ﹤0.01% 243
2022
Q3
$9K Buy
+626
New +$9.66K ﹤0.01% 217

Other funds holding KURA

China Universal Asset Management Company's KURA Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Kura Oncology (KURA) stake by 8.5% in Q2 2026, selling an estimated $12.4K and leaving 14,128 shares worth $155K. The position accounts for 0.01% of the portfolio, ranked #375.

China Universal Asset Management Company first reported a position in KURA in Q3 2022 and has held it in 16 quarters since. The position peaked at $333K in Q1 2024. 117 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • China Universal Asset Management Company held 14,128 shares of Kura Oncology worth $155K as of Q2 2026.
  • China Universal Asset Management Company sold 1,314 Kura Oncology shares in Q2 2026, an estimated $12.4K.
  • Kura Oncology made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #375 holding.
  • China Universal Asset Management Company first reported a position in Kura Oncology in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Kura Oncology position peaked at $333K in Q1 2024.
  • 117 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.